Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2008

View Archived Issues

FDA advisory committee recommends approval of Chugai and Roche's Actemra in RA

Integrated BioPharma sets record and distribution dates for spin-off of iBioPharma

[11C]-AFM, a novel PET imaging agent to visualize serotonin transporters

FDA accepts for filing Meda's registration application for Sublinox

Zogenix secures financing to launch sumatriptan DosePro

Chroma Therapeutics' CHR-3996 histone deacetylase inhibitor to be evaluated in a phase I study

Phase II results of AL-108 for amnestic MCI presented at ICAD meeting

Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice

Millennium presents an update on clinical development

Pronucleon peptide technology effective for beta amyloid imaging in mice

Lexicon reports results from phase I study of LX-1031 in IBS

Inspire modifies clinical protocol for phase III TIGER-2 trial of denufosol tetrasodium in CF

Intercept completes USD 25 million equity financing

GSK launches Volibris for pulmonary arterial hypertension in the U.K.

Ariad initiates phase II clinical trial of deforolimus in breast cancer

Hollis-Eden initiates phase I/II clinical trial of Apoptone in late-stage prostate cancer

FDA approves Noven's Stavzor for bipolar disorder, seizures and migraine headaches

Novel antiinfective agents reported in recent patents

Idenix presents an update on the company's clinical development plans

Bristol-Myers Squibb prepares and tests novel factor VIIa inhibitors

New agents for diagnosis of congestive heart failure described in BMS patent

ReceptoPharm successfully completes phase IIb/IIIa clinical trial of RPI-78M in AMN

Regulatory approval of Basilea's Toctino recommended under European decentralized procedure

Infinity initiates phase I clinical trial of IPI-493 in advanced solid tumors

Othera submits IND application to FDA for OT-730 in glaucoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...